Jing Lai
department
Infectious Disease
Introduction

Jing Lai, Ph.D.

?

Title

Deputy Director Physician

Infectious Disease Department

The Third Affiliated Hospital of the Sun Yat-sen University.

?

Research Interests

  • Clinical diagnosis and treatment of infectious diseases, especially viral hepatitis

  • The pathogenesis of HBV infection

  • High medical education of Infectious Diseases

Dr. Jing is an infectious diseases physician since 1994. She has engaged in the clinical medicine, teaching and research of infectious diseases over twenty years and is the current deputy director physician in the Infectious Diseases Department. Her work focuses on viral hepatitis, especially the relation of host genetic polymorphism with clinical outcomes of HBV infection and its pathogenesis. She is also engaged in the field of antiviral therapies of viral hepatitis, noninvasive assessment of liver fibrosis. Dr. Jing Lai's other interests include the infectious diseases clinical teaching reform in higher medical education.

?

Education and Experience

Education

Bachelor degree of Clinical Medicine, the Sun Yat-Sen Medical University (1994)

Master degree of Clinical Medicine (internal ? ? ?medicine specialty), the Sun Yat-Sen University (2004)

Doctor degree of Clinical Medicine ? ? ?(internal medicine specialty), the Sun Yat-Sen ? ? ?University (2009)

Experience

Lai Jing works in Infectious Disease Department, the Third Affiliated Hospital of the Sun Yat-Sen University since July, 1994. She joined the hospital as a resident, and was promoted to become Doctor in Charge and then the Deputy Director Physician in 2013. She has engaged in clinical medicine, higher medical education teaching and the infectious disease research for more than twenty years.

?

Honors and Awards

She focuses on the relation between clinical outcome of HBV infection and host genetic susceptibility since 2006 and had headed three funded studies.

1. The relation between gene polymorphisms of HLA-DQB1 combined with HLA -DQA1 and hepatitis B virus related acute-on-chronic liver failure. Natural Science Foundation of Guangdong Province (S2011040002457).

2. The relation of gene polymorphism of human leukocyte antigen-DRB1 with severe hepatitis B. Medical Science and Technology Research Foundation of Guangdong Province (A2011187).

3. The research of hepatitis B virus associated acute-on-chronic liver failure and the gene polymorphism of human leukocyte antigen-II. Science and Technology Project of Guangdong Province (2010 1096).

?Furthermore, she is awarded the excellent service physician, teacher in the comprehensive assessment in the previous year.

?

Publications

The main original articles that were published in the past five years as the following:?

[1] Lai J, Sun HX, Jie YS, Zhang K, Ke WM. Serum HBsAg level and its clinical significance in lamivudine treatment for patients with HBeAg-negative acute -on-chronic liver failure. Int J Infect Dis. 2014;22: 78-82.

[2] Lai J, Lin CS, Yang L, Chen SR, Zhang YQ, Ke WM. Pretreatment HBsAg level and an early decrease in MELD score predict prognosis to lamivudine treatment for HBeAg-negative acute-on-chronic liver failure. Clin Res Hepatol Gastroenterol. 2014; 38:331-336.

[3] Lai J, Yan Y, Mai L, Zheng YB, Gan WQ and Ke WM. Short-term entecavir versus Lamivudine Therapy for HBeAg-negative Patients with Acute-on-chronic hepatitis B Liver Failure. Hepatobiliary Pancreat Dis Int 2013; 12(2):154-159.

[4] Lai J, Gan WQ, Xie DY, Zhang K, Ke WM, Gao ZL. Dynamics of serum HBV DNA levels during the terminal phases of different HBeAg status acute-on- chronic liver failure. Chin J Hepatol, 2012; 20(7): 522-525

[5] Lai J , Yan Y, MAI L, Chen HW, Zheng XY, Ke WM, Gao ZL. Lamivudine versus Entecavir for Patients with HBeAg-negative Acute-on-chronic Liver Failure. Chin J Infect Dis 2012; 30(6): 349-353.

[6 ] Lai J, Zhang SQ, Li XJ, Zhu JY, Ke WM. Study of HBV DNA loads and MELD scores in patients with different HBeAg status acute-on-chronic hepatitis B liver failure during terminal phases. Chin Exp Clin Virol, 2012; 26(1): 51-53.

?[7] Lai J, Zhang SQ, YAN Y, Lin CSh, Ke WM. Efficacy of Liver Failure Status on Patients Treated with Lamivudine in HBeAg-negative acute-on-chronic Liver Failure. J Sun Yat-sen University (Medical Sciences), 2012; 33(1): 71-74.

?

Contact

Department of Infectious Disease

The Third Affiliated Hospital of the Sun Yat-sen University

No 600# Tianhe Road, Guangzhou, 510630, P. R. China

Appointment Phone: 02085252372

?